Friday, June 19, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 22 of 1,261
  1. US 12384797

    Thioeno[3,2-b] pyridin-7-amine compounds for treating familial dysautonomia

    PTC THERAPEUTICS, INC. · Granted Aug 12, 2025 · Expires Aug 7, 2045

    granted
  2. US 12384762

    Modulator of the Cystic Fibrosis Transmembrane Conductance Regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator

    Vertex Pharmaceuticals Incorporated · Granted Aug 12, 2025 · Expires Aug 7, 2045

    granted
  3. US 12383567

    Use of cannabinoids in the treatment of epilepsy

    JAZZ PHARMACEUTICALS RESEARCH UK LIMITED · Granted Aug 12, 2025 · Expires Aug 7, 2045

    granted
  4. US 12383631

    Immune antigen specific IL-18 immunocytokines and uses thereof

    Bright Peak Therapeutics AG · Granted Aug 12, 2025 · Expires Aug 7, 2045

    granted
  5. US 12384750

    Ras inhibitors

    Revolution Medicines, Inc. · Granted Aug 12, 2025 · Expires Aug 7, 2045

    granted
  6. US 12384779

    Bicyclic compounds

    Aligos Therapeutics, Inc. · Granted Aug 12, 2025 · Expires Aug 7, 2045

    granted
  7. US 12383627

    Antimicrobial scaffolds

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Aug 12, 2025 · Expires Aug 7, 2045

    granted
  8. US 12384775

    Pyrimid-2-yl-pyrazole compounds as IRAK inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Aug 12, 2025 · Expires Aug 7, 2045

    granted
  9. US 12384744

    Enzyme-cleavable methadone prodrugs and methods of use thereof

    Ensysce Biosciences Inc. · Granted Aug 12, 2025 · Expires Aug 7, 2045

    granted
  10. US 12383652

    Nanofiber structures and methods of manufacture and use thereof

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Aug 12, 2025 · Expires Aug 7, 2045

    granted
  11. US 12385010

    Gene therapy for recessive dystrophic epidermolysis bullosa using genetically corrected autologous keratinocytes

    United States Government as represented by the Department of Veterans Affairs · Granted Aug 12, 2025 · Expires Aug 7, 2045

    granted
  12. US 12383503

    Adagrasib solid pharmaceutical compositions

    Mirati Therapeutics, Inc. · Granted Aug 12, 2025 · Expires Aug 7, 2045

    granted
  13. US 12383534

    Methods for treating cancer

    Regents of the University of Minnesota · Granted Aug 12, 2025 · Expires Aug 7, 2045

    granted
  14. US 12383516

    Albuterol aerosol suspension formulation for oral inhalation with high amount of green propellant hydrofluoroolefin (HFO) and free of co-solvent

    Amphastar Pharmaceuticals, Inc. · Granted Aug 12, 2025 · Expires Aug 7, 2045

    granted
  15. US 12383522

    Baclofen formulations and methods of minimizing patient exposure to metabolite variations

    AMNEAL PHARMACEUTICALS LLC · Granted Aug 12, 2025 · Expires Aug 7, 2045

    granted
  16. US 12383535

    Hydrogen peroxide-responsive KEAP1-NRF2 ppi inhibitor prodrug, and preparation method therefor

    CHINA PHARMACEUTICAL UNIVERSITY · Granted Aug 12, 2025 · Expires Aug 7, 2045

    granted
  17. US 12383540

    Compounds that modulates AMPA receptor function

    University College Cardiff Consultants Limited · Granted Aug 12, 2025 · Expires Aug 7, 2045

    granted
  18. US 12384776

    Compounds and uses thereof

    FOGHORN THERAPEUTICS INC. · Granted Aug 12, 2025 · Expires Aug 7, 2045

    granted
  19. US 12383560

    Compounds and uses thereof

    FOGHORN THERAPEUTICS INC. · Granted Aug 12, 2025 · Expires Aug 7, 2045

    granted
  20. US 12384830

    Compositions and methods for improving immunotherapy

    Regents of the University of Minnesota · Granted Aug 12, 2025 · Expires Aug 7, 2045

    granted
  21. US 2025250277

    PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-a]PYRROLO[2,3-e]-PYRAZIN-8-YL)-N-(2,2,2-TRIFLUOROETHYL)PYRROLIDINE-1-CARBOXAMIDE AND SOLID STATE FORMS THEREOF

    ABBVIE INC [US] · Granted Aug 7, 2025 · Expires Aug 2, 2045

    granted
  22. WO 2025165930

    MÉTHODES DE TRAITEMENT DE L'AMYOTROPHIE SPINALE

    BIOGEN MA INC [US] · Granted Aug 7, 2025 · Expires Aug 2, 2045

    granted
  23. US 12378193

    Anti-arrhythmicity agents

    The Regents of the University of California · Granted Aug 5, 2025 · Expires Jul 31, 2045

    granted
  24. US 12378256

    Heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Aug 5, 2025 · Expires Jul 31, 2045

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.